We are thrilled to introduce Ken Keller, Chairman of the Board, President and CEO of Daiichi Sankyo, as our esteemed keynote speaker at the upcoming Fierce JPM Week in San Francisco on January 9-10th. With more than 30 years of experience in the pharmaceutical industry, Ken has led multi-billion dollar businesses in both U.S. and Europe while working to unify cross-functional teams to create a global infrastructure – enabling the commercial success of Daiichi Sankyo oncology and specialty medicines. Mr. Keller will join C-Level executives from Novartis, Bayer, Gilead, ReCode Therapeutics, Kura Oncology, Beam Therapeutics, and Astellas, among others, as they share their insights, experiences and outlook for 2024. VIEW THE AGENDA>> The Early Bird Rate Ends December 1st! Register now and save up to $450 before prices increase. Only 25 passes are left at this rate so secure your spot now. |